ÂÜÀòÂÒÂ×

Richard E. Showalter has a diverse work experience spanning over several decades. Richard E. began their career as a Research Associate at the Agouron Institute in 1984, where they contributed to the development of molecular genetic tools and made significant discoveries in bacterial communication and potential antibacterial agents. In 1992, they joined the California Department of Justice as a Criminalist-DNA Crime Lab, specializing in forensic DNA analysis and providing support for the development of a DNA database. Moving into the pharmaceutical industry, Showalter worked as a Research Scientist II at Agouron Pharmaceuticals/Warner Lambert/Pfizer from 1993 to 2001, focusing on drug discovery in various therapeutic areas and leading projects in neurodegenerative diseases. Richard E. then joined Anadys Pharmaceuticals/Roche as an Associate Research Fellow, where they played a crucial role in drug discovery projects, protein engineering, and project leadership. Since 2012, Showalter has been associated with Polaris Pharmaceuticals, where they initially served as a Senior Research Fellow in Structural Biology before progressing to the role of Executive Director, Discovery Research. Currently, they hold the position of Vice President of Research and Development at Polaris Pharmaceuticals. Throughout their career, Showalter has demonstrated a strong expertise in research and development, project leadership, and drug discovery across different industries and organizations.

Richard E. Showalter's education history includes a Certificate in Forensic Science and Technology from the California Criminalistics Institute, which they obtained from 1992 to 1993. Prior to that, from 1983 to 1984, they received a Certificate in Recombinant DNA Techniques from San Diego State University. Richard E.'searliest education experience was at UC San Diego, where they pursued a Bachelor of Arts (B.A.) degree in Biochemistry and Molecular Biology from 1978 to 1983.